Multi-Layer Nicotine-Containing Pharmaceutical Composition
Patent No. EP3735972 (titled "Multi-Layer Nicotine-Containing Pharmaceutical Composition") was filed by Modoral Brands on Feb 7, 2013. The application was issued on Nov 19, 2025.
Patent Summary
This pharmaceutical composition for oral delivery of a nicotinic compound comprises a core formulation surrounded by one or more continuous layers of different formulations. The core and surrounding layers possess distinct organoleptic properties. The core formulation is specifically provided as a granular powder, and the composition features a nicotinic compound sorbed onto a porous particulate carrier. The multi-layered structure may utilize various formulation types, including lozenge, meltable, chewable, hard coating, or molded (starch or injection) forms, to achieve modified delivery profiles, such as fast or extended release. The composition is intended for therapeutic use, including as a smoking cessation aid or for treating conditions responsive to nicotinic acetylcholinergic receptor stimulation.
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP3735972
- Application Number
- EP20168687A
- Filing Date
- Feb 7, 2013
- Status
- Granted And Under Opposition
- Oct 17, 2025
- Publication Date
- Nov 19, 2025
- External Links
- Slate, Register , Google Patents